PostEra’s Fertility programs acquired by EMD Serono, Inc.
BOSTON, Sept. 9, 2026 /PRNewswire/ — PostEra, a biotechnology company specializing in artificial intelligence for small molecule drug discovery and reproductive endocrinology, today announced that EMD Serono, Inc., the Healthcare business of
